Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Privia Health Group (PRVA)
NASDAQ:PRVA
Holding PRVA?
Track your performance easily
See the Price Targets and Ratings of:
PRVA Analyst Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PRVA Stock 12 Month Forecast
Average Price Target
$24.64
▲(16.45% Upside)
| Highest Price Target$28.00 | Average Price Target$24.64 | Lowest Price Target$19.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Assigned
10/31/24
Evercore ISI
Assigned
10/30/24
KeyBanc
Initiated
10/10/24
William Blair
Reiterated
10/01/24
Truist Financial
Reiterated
09/04/24
J.P. Morgan
Reiterated
08/26/24
Robert W. Baird
Reiterated
08/26/24
RBC Capital
Assigned
08/22/24
TD Cowen
Reiterated
08/09/24
Piper Sandler
Assigned
08/09/24
Canaccord Genuity
$26
Buy
22.87%
Upside
Reiterated
08/08/24
Buy Rating Affirmed for Privia Health Group Amid Solid Financials and Positive 2024 Outlook
Leerink Partners
$26
Buy
22.87%
Upside
Reiterated
08/08/24
Analysts Are Bullish on Top Healthcare Stocks: Celldex (CLDX), Privia Health Group (PRVA)
JMP Securities
$25
Buy
18.15%
Upside
Reiterated
08/08/24
Privia Health Group's Strong Q2 Performance and Upward Outlook Prompt Buy Rating
Jefferies
$25
Buy
18.15%
Upside
Reiterated
05/15/24
We believe concerns around margins & FCF are addressable while in-line results against a challenging back- drop for VBC businesses deserve credit. From current levels at <20x FY25 EBITDA we think the story is simple: an achievable +20% medium term EBITDA growth outlook & best-in-class FCF characteristics warrant a higher multiple. Reit Buy, PT to $25 (26x FY25 EBITDA based on coverage EV/EBITDA-to- Growth). 1Q24 the Board. PRVA delivered a solid 1Q24 with top-line & volume KPIs (Implemented Providers & Attributed Lives) tracking modestly ahead of Street -- perhaps implying some upside vs. the FY24 top-line guide -- while Care Margin & EBITDA were largely in line.
Bank of America Securities
$21
Hold
-0.76%
Downside
Reiterated
05/09/24
Privia Health Group: Hold Rating Maintained Amid Steady Performance and Cautious Outlook
Best Analysts Covering Privia Health Group
Which Analyst Should I Follow If I Want to Buy PRVA and Sell After:
1 Month
xxx
Success Rate
7/18 ratings generated profit
Average Return
+0.13%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.89% of your transactions generating a profit, with an average return of +0.13% per trade.
3 Months
xxx
Success Rate
8/18 ratings generated profit
Average Return
+0.72%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +0.72% per trade.
1 Year
2 Years
xxx
Success Rate
2/18 ratings generated profit
Average Return
-16.45%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -16.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRVA Analyst Recommendation Trends
Rating
May 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
2
1
1
0
0
Buy
12
10
20
13
15
Hold
4
3
3
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
14
24
14
17
Each month's total comprises the sum of three months' worth of ratings.
PRVA Financial Forecast
PRVA Stock Forecast FAQ
What is PRVA’s average 12-month price target, according to analysts?
Based on analyst ratings, Privia Health Group’s 12-month average price target is $24.64.
What is PRVA’s upside potential, based on the analysts’ average price target?
Privia Health Group has 16.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRVA a Buy, Sell or Hold?
Privia Health Group has a consensus rating of Strong Buy which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
What is Privia Health Group’s price target?
The average price target for Privia Health Group is $24.64. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.00 ,the lowest forecast is $19.00. The average price target represents 16.45% Increase from the current price of $21.16.
The highest analyst price target is $28.00 ,the lowest forecast is $19.00. The average price target represents 16.45% Increase from the current price of $21.16.
What do analysts say about Privia Health Group?
Privia Health Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of PRVA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.